Share on LinkedInShare on LinkedIn

ARTICLE · 04 DECEMBER 2008

Competition Bureau Releases Follow-Up Report On Generic Drug Competition

On November 25, 2008, the Competition Bureau released its second report, Benefiting from Generic Drug Competition in Canada: The Way Forward, on the competitive framework for generic drugs in Canada.

CanadaAntitrust/Competition Law

On November 25, 2008, the Competition Bureau released its second report, Benefiting from Generic Drug Competition in Canada: The Way Forward, on the competitive framework for generic drugs in Canada. In her speech announcing the report, the Commissioner of Competition characterized it as "a timely prescription for change". The objective of the report was to examine and recommend ways for Canadians to obtain the full benefits of generic drug competition. In addition to providing an update on generic drug pricing and the development of public and private plans in Canada, the Bureau's report includes specific recommendations for public and private plans.

Benefiting from Generic Drug Competition in Canada: The Way Forward

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from